Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by NeonMind Biosciences Inc.

NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows
From NeonMind Biosciences Inc.
Via AccessWire
Tickers CSE:NEON NMDBF
NeonMind to Present at H.C. Wainwright 2nd Annual Psychedelics Virtual Conference
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Announces Successful Completion of Pre-IND Consultation with FDA on Clinical Path for Obesity Drug Candidate NEO-001
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers CSE:NEON NMDBF
NeonMind to Participate in Panel Discussion at Lift & Co. Expo's Psychedelics Business Summit on November 19, 2021
From NeonMind Biosciences Inc.
Via AccessWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind and SRx Health Solutions Announce Strategic Alliance to Establish Specialty Mental Health Clinics for Interventional Psychiatry Treatments
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Biosciences Named as a Top Industry Innovator in Inaugural Issue of Psychedelia Magazine
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Advances Strategy for Specialty Clinic Launch
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD.
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Announces Divestiture of Consumer Related and Other Non-Core Assets
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers CSE:NEON NMDBF
NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Announces DTC Eligibility
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Receives Health Canada Approval for its Functional Mushroom Formulation 'Mindful Blend'
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Announces Corporate Update and Strategic Reorganization of its Pharmaceutical Division
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers CSE:NEON NMDBF
Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Provides Integrated Drug Development Plan Update for NEO-001 to Treat Obesity
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property
Tickers CSE:NEON NMDBF
NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US
From NeonMind Biosciences Inc.
Via AccessWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers CSE:NEON NMDBF
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.